Plant-based cures for Vector-borne disease
…
Continue Reading about Plant-based cures for Vector-borne disease →
Learn more about lower prices for select testing with a collection date of September 15th to December 31st, 2022 here.
We offer a growing menu of DNA and antibody test options that lead to more accurate diagnoses.
Both animals and the professionals who provide them with care are at a high risk for Bartonella infections.
We offer contract research services to support universities, biotech companies, and more.
We offer the most sensitive direct detection tests available for confirmation of Bartonella species infections, such as cat scratch fever.
The Bartonella Digital ePCR™ platform combines highly sensitive ddPCR technology with BAPGM™ enrichment. The sensitivity and specificity of our test offerings are supported extensively by peer-reviewed publications. Importantly, our technology also contributes to furthering the clinical understanding of Bartonella infections impacting both people and animals through collaborations at leading research institutions.

Our mission is to research, educate, and build awareness for important vector-borne diseases among the key stakeholders in the medical, public health, and veterinary communities. We believe utilizing advanced testing methodologies that directly detect DNA or proteins of flea and tick-borne pathogens in patient samples is critical to accomplishing this goal. Galaxy Diagnostics is dedicated to developing sample enrichment technologies that enhance our direct detection capabilities and allow us to confirm infections that are often missed by conventional testing.

6 Davis Drive, Suite 201
Research Triangle Park, NC 27709
P: 919-313-9672
F: 919-287-2476
E: contact@galaxydx.com
